Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children.

Polat, MELTEM; Kara, Soner; TAPISIZ, ANIL; TEZER, HASAN; Kalkan, Gokhan; Dolgun, Anil

doi:10.1007/s40272-015-0133-5

Treatment of Ventilator-Associated Pneumonia Using Intravenous Colistin Alone or in Combination with Inhaled Colistin in Critically Ill Children.

Atıf İçin Kopyala

Polat M., Kara S. S., TAPISIZ A., TEZER H., Kalkan G., Dolgun A.

Paediatric drugs, cilt.17, sa.4, ss.323-30, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 17 Sayı: 4
Basım Tarihi: 2015
Doi Numarası: 10.1007/s40272-015-0133-5
Dergi Adı: Paediatric drugs
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.323-30
Gazi Üniversitesi Adresli: Evet

Özet

Objective The objective of this study was to compare the safety and efficacy of inhaled plus intravenous (IV) colistin with that of IV colistin alone in critically ill children with ventilator-associated pneumonia (VAP) due to colistin-only susceptible (COS) Gram-negative bacteria (GNB).